pharmaceutical industryIdeasThe US Is Paying Way Too Much for RemdesivirBy Rohan Chalasani and Walid GelladScienceThe CEO of Novartis on Developing Drugs During a PandemicBy Steven LevyScienceThe Dangers of Excluding Women From HIV Prevention Drug TestsBy Michele Cohen MarillScienceCovid-19 Stalls Clinical Trials for Everything but Covid-19By Jared WhitlockScienceThe FDA Asks Companies to Stop Selling RanitidineBy Michele Cohen MarillThe Big StoryJapan Is Racing to Test a Drug to Treat Covid-19By Joshua HuntScienceThe Ibuprofen Debate Reveals the Danger of Covid-19 RumorsBy Maryn McKennaThe Big StoryThe Mom Who Took on Purdue Pharma for Its OxyContin MarketingBy Gerald PosnerScienceThe Coronavirus Is a Threat to the Global Drug SupplyBy Michele Cohen MarillScienceThree Ways to Fix the Drug Industry's Rampant DysfunctionBy Michele Cohen MarillSciencePharma Spending on Doctors Is Correlated With Opioid DeathsBy Eric NiilerScienceDietary Supplements Can Contain Viagra, Steroids, or WorseBy Emily DreyfussScienceThe New War on (Overpriced) DrugsBy David FerryScienceThe Tricky Ethics of Big Pharma Soft-Selling on Soap OperasBy Nick StocktonOpinionThe FDA Is Broken. Here’s How to Fix ItBy David GortlerDesignPharmacies Are Awful—But These Startups Could Fix ThemBy Margaret RhodesBusinessInternet Rejoices as Reviled Pharma Kingpin Martin Shkreli Is ArrestedBy Issie LapowskyScienceWhy Testing Drugs on Our Dogs Is Good for Our HealthBy Jonathon KeatsDesignEver Seen These Pics of MDMA and LSD? Dude, They're IntenseBy Joseph FlahertyBusinessFather-Son Duo Reinvent Drug Testing With 'Digital Lab Rats'By Daniela HernandezSecurityHow a Career Con Man Led a Federal Sting That Cost Google $500 MillionBy Jake PearsonScienceFlushed Drugs May Threaten Stream EcologiesBy Erik StokstadScienceSearch-Engine Data Gives Early Warnings of Drug Side EffectsBy ScienceNowScienceDocs Pushing More Hard Drugs on KidsBy David DobbsMore Stories
